# Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multiple Sclerosis in a Clinical Setting

> **NCT06261541** · NA · COMPLETED · sponsor: **ABLE Human Motion S.L.** · enrollment: 33 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DEVICE:** ABLE Exoskeleton

## Key facts

- **NCT ID:** NCT06261541
- **Lead sponsor:** ABLE Human Motion S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-08
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2024-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06261541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06261541, "Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multiple Sclerosis in a Clinical Setting". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06261541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*